Global Hyaluronic Acid Products Market Driven by High Demand for Anti-ageing Products, to Reach US$9.85 bn by 2019 The global hyaluronic acid products market was recorded at US$5.32 bn in 2012. Owing to a few high-impact drivers, this market is expected to reach US$9.85 bn by the end of 2019, progressing at a CAGR of 9.2% within a forecast period from 2013 to 2019. The statistical and factual data is presented in a research report published by leading market intelligence agency, Transparency Market Research. The report, “Hyaluronic Acid Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,� provides concise details on the why this market is behaving the way it is, and how it can be expected to fare in the near future. Hyaluronic acid performs multiple functions in the human body. It is a type of glycosaminoglycan, which is distributed throughout the body in epithelial tissues, neural tissues, and connective tissues. Hyaluronic acid performs the crucial role of retaining water in body tissues and transporting nutrients through the body. When a person suffers from conditions such as inflammation, wound healing, and cancer, hyaluronic acid creates a flexible yet protective layer around the body cell. Hyaluronic acid is therefore an important component that is naturally present in human body. It is found in high concentrations in fluids in the eyes and around the joints.
Given its inherent advantages, hyaluronic acid (HA) exhibits a wide range of applications in ophthalmology, dermatology, rheumatology, orthopedic surgery, otolaryngology, plastic surgery, drug delivery, and wound healing. According to a recently published report by Transparency Market Research, a leading U.S.-based market intelligence firm, the global hyaluronic acid products market is poised to grow at a progressive 9.2% CAGR from 2013 to 2019. The market for hyaluronic acid products was valued at US$5.32 billion in 2012 and is expected to reach a total value of US$9.85 billion by the end of 2019. To understand the market viability of the hyaluronic acid products, the market can be segmented in terms of treatment regimen into five-injection cycle, three-injection cycle, and single-injection cycle products. HA injectibles are readily available in the market and are widely used across applications such as ophthalmic surgery, dermal fillers, osteoarthritis, and vesicoureteral reflux (VUX). In the last couple of years the demand for hyaluronic acid products has exponentially increased. Impelled by the growing geriatric population and growing awareness among people about antiaging procedures, the hyaluronic acid products market is anticipated to expand considerably in